Digital tests for generalized myasthenia gravis using a smartphone
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have been diagnosed with generalized myasthenia gravis (MG) and have a blood test showing anti–acetylcholine receptor (anti-AChR) antibodies
- Have not had certain treatments recently: plasma exchange, intravenous immunoglobulin (IVIG), or thymus gland surgery (thymectomy) within the last 4 weeks
- Not start certain new medicines recently: FcRn inhibitor therapy within the last 4 weeks
- Have a personal smartphone (iPhone software > 13 or Android software > 8) and can use it
- Can read French, English, or Spanish and understand the app pictures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses digital tools like questionnaires and smartphone tests to measure how myasthenia gravis affects you. It aims to create a better way for doctors to track your symptoms and adjust treatment.
This study uses wearable sensors and smartphone apps to track your myasthenia gravis symptoms over time. It aims to see how well these technologies can measure your condition in daily life, which could help you and your doctor manage your care better.
This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.
This study follows people with suspected or confirmed myasthenia gravis (a condition that causes muscle weakness that gets worse with use). It uses several specialized nerve and antibody tests to make a more precise diagnosis and tracks you over time to see how well these methods work.
This trial tests multiple treatment combinations for people with myasthenia gravis (MG), a condition that causes muscle weakness. It aims to find safer and more effective options by comparing different therapies.
This study is a patient registry that tracks the experiences of people with myasthenia gravis over time. It aims to better understand the condition and improve care, using a smartphone, tablet, or computer to share information.
Hear when a new Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.